(607) 227-8695info@prendismo.com

Colin Hill States Computer Models Increase Probability For Pharmaceutical Companies To Get New Drugs To Market

Copyright © Cornell University Play All Videos in Case

Total Case Duration :

  • Date Added : 3/27/06
  • Clip Duration : 2 min. 18 sec.

Playlists

Please Login to create playlists

Colin Hill

  • CEO, President and Co-founder, Gene Network Sciences
  • male
  • AfricanAmerican
  • 1974 (Age: 50 years old)
  • Colin Hill - Lecture - Gene Network Sciences
  • Video 1 of 19 in this Case
  • View All Available Videos

Biography

Colin Hill is Chairman and CEO of Gene Network Sciences. In this role, Hill develops the strategic roadmap and vision for the company and oversees the leadership of business operations. Hill brings years of hands-on scientific experience to his role, with expertise in the areas of computational physics and systems biology. Colin Hill was recently named to MIT Technology Review's TR100 list of the top innovators in the world under the age of 35, and was also selected by Black Enterprise as the winner of the 2004 "Rising Star" small business award. Colin Hill graduated from Virginia Tech with a degree in physics and went on to earn masters degrees in physics from McGill and Cornell Universities.

So who cares, like what does this actually do and why would a pharmaceutical company pay money for it. So for pharmaceutical companies, the bottom line benefit is the following. These data driven computer models increase the probability of getting a pre-clinical drug to market and that's the whole...(Full transcript available to logged in subscribers.).

Register & Subscribe Login

Colin Hill videos

Video 1 of 19 Colin Hill States Poor Understanding Of Human Biology Leads To Medical Problems That GNS Is Trying To Solve
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 3 min. 6 sec.
Video 2 of 19 Colin Hill Outlines Background of Company, Gene Network Sciences (GNS)
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 2 min. 4 sec.
Video 3 of 19 Colin Hill Discusses Human Genome Project And Impact of Bioinformatics
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 3 min. 47 sec.
Video 4 of 19 Colin Hill States Computer Models Increase Probability For Pharmaceutical Companies To Get New Drugs To Market
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 2 min. 18 sec.
Video 5 of 19 Colin Hill Discusses Software Technology That GNS Uses To Simulate And Predict Drug Outcomes
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 5 min. 29 sec.
Video 6 of 19 Colin Hill Discusses Process of Cancer Drug Development
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 2 min. 17 sec.
Video 7 of 19 Colin Hill States GNS Is Working To Determine Drugs That Will Impact Cardiac Risk
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 1 min. 14 sec.
Video 8 of 19 Colin Hill Discusses GNS' Work With Cancer Treatment Center
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 0 min. 54 sec.
Video 9 of 19 Colin Hill States GNS Technology Will Play Part In Curing Cancer
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 0 min. 40 sec.
Video 10 of 19 Colin Hill Discusses Educational Background and Decision To Found GNS
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 2 min. 56 sec.
Video 11 of 19 Colin Hill States Ethical Issues Are At Center of Bioinformatics
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 1 min. 29 sec.
Video 12 of 19 Colin Hill Discusses Challenge Of Building Commercial Aspect To GNS
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 2 min. 57 sec.
Video 13 of 19 Colin Hill Outlines How GNS Makes Money
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 3 min. 27 sec.
Video 14 of 19 Colin Hill Discusses Evolution From Pursuing Pharmaceutical Industry To Pursuing Cancer Patient Industry As Well
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 2 min. 18 sec.
Video 15 of 19 Colin Hill States Company Started With Very Limited Capital
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 0 min. 57 sec.
Video 16 of 19 Colin Hill Discusses Accuracy Of GNS Technology
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 0 min. 50 sec.
Video 17 of 19 Colin Hill Discusses Challenges of Insurance Reimbursement For GNS Services
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 0 min. 48 sec.
Video 18 of 19 Colin Hill States Challenge Of Running A Business When You Are A Scientist At Heart
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 2 min. 12 sec.
Video 19 of 19 Colin Hill States Developing A Cure And Making Money Need To Go Hand In Hand As Business Evolves
  • Colin Hill - Lecture - Gene Network Sciences
  • 3/27/06
  • Colin Hill
  • 2 min. 6 sec.